Methods, Kits, And Systems For Scoring The Immune Response To Cancer By Simultaneous Detection Of Cd3, Cd8, Cd20 And Foxp3

Patent No. EP3111221 (titled "Methods, Kits, And Systems For Scoring The Immune Response To Cancer By Simultaneous Detection Of Cd3, Cd8, Cd20 And Foxp3") was filed by Ventana Medical Systems on Feb 20, 2015. The application was issued on Jan 19, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
CMS CAMERON MCKENNA NABARRO OLSWANGJul 10, 2019CMS CAMERON MCKENNA NABARRO OLSWANG

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3111221

VENTANA MEDICAL SYSTEMS
Application Number
EP15706450A
Filing Date
Feb 20, 2015
Status
Patent Maintained As Amended
Dec 17, 2021
Publication Date
Jan 19, 2022